Literature DB >> 14597092

Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels.

Deming Sun1, Volker Enzmann, Song Lei, Sheher L Sun, Henry J Kaplan, Hui Shao.   

Abstract

The retinal pigment epithelium (RPE) plays an important role in maintaining the privileged status of the eye. In this study, we examined the outcome of the in vitro interaction between uveitogenic T cells and non-activated or activated RPE cells. An interphotoreceptor retinoid-binding protein (IRBP)-reactive T cell line was established and RPE cell monolayers prepared. The expression of MHC class II molecules on RPE cells activated by graded doses of IFN-gamma was determined by flow cytometry. Proliferation and cytokine production of IRBP-reactive T cells were measured after exposure to IFN-gamma-activated RPE cells. We found that RPE cells expressed various levels of MHC class II molecules depending on the concentration of IFN-gamma used. IRBP-specific T cells could be stimulated or inhibited by exposure to RPE cells. The dual effect of RPE cells might be regulated via different levels of MHC class II molecules on the RPE cells. It suggests that controlling the immune activities of uveitogeneic T cells by varying the levels of MHC class II expression on the RPE might be one of the regulatory mechanisms by which the RPE maintains immune privilege in the eye.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597092     DOI: 10.1016/s0165-5728(03)00248-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis.

Authors:  Zhidan Tu; Yan Li; Dawn Smith; Catherine Doller; Sunao Sugita; Chi-Chao Chan; Shiguang Qian; John Fung; Rachel R Caspi; Lina Lu; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

2.  PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells.

Authors:  Yan Ke; Deming Sun; Guomin Jiang; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2010-08-25       Impact factor: 4.962

Review 3.  Major histocompatibility complex molecules on parenchymal cells of the target organ protect against autoimmune disease.

Authors:  Hui Shao; Henry J Kaplan; Deming Sun
Journal:  Chem Immunol Allergy       Date:  2007

4.  Retinal Astrocytes respond to IL-17 differently than Retinal Pigment Epithelial cells.

Authors:  Yan Ke; Guomin Jiang; Deming Sun; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2009-08-18       Impact factor: 4.962

5.  Pro-angiogenic effect of IFNgamma is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells.

Authors:  Baoying Liu; Lisa Faia; Mengjun Hu; Robert B Nussenblatt
Journal:  Mol Vis       Date:  2010-02-10       Impact factor: 2.367

6.  Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice.

Authors:  Guomin Jiang; Yan Ke; Deming Sun; Gencheng Han; Henry J Kaplan; Hui Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

7.  Successful Transplantation of Retinal Pigment Epithelial Cells from MHC Homozygote iPSCs in MHC-Matched Models.

Authors:  Sunao Sugita; Yuko Iwasaki; Kenichi Makabe; Hiroyuki Kamao; Michiko Mandai; Takashi Shiina; Kazumasa Ogasawara; Yasuhiko Hirami; Yasuo Kurimoto; Masayo Takahashi
Journal:  Stem Cell Reports       Date:  2016-09-15       Impact factor: 7.765

Review 8.  Immune Privilege and Eye-Derived T-Regulatory Cells.

Authors:  Hiroshi Keino; Shintaro Horie; Sunao Sugita
Journal:  J Immunol Res       Date:  2018-05-20       Impact factor: 4.818

9.  Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa.

Authors:  K Varsha Mohan; Alaknanda Mishra; Abaranjitha Muniyasamy; Prakriti Sinha; Parul Sahu; Ashwani Kesarwani; Kshama Jain; Perumal Nagarajan; Vinod Scaria; Manisha Agarwal; Naseem S Akhter; Chanda Gupta; Pramod Upadhyay
Journal:  Orphanet J Rare Dis       Date:  2022-10-17       Impact factor: 4.303

10.  OX40 ligand expression abrogates the immunosuppressive function of retinal pigment epithelium.

Authors:  Matthew A Cunningham; Zhuqing Li; Baoying Liu; Steven Yeh; Robert B Nussenblatt
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.